StockData
Bicara Therapeutics Inc. logo

Bicara Therapeutics Inc. (BCAX) stock

BCAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$9.75−0.27 (-2.69%)

Close on Nov 16, 2026Market cap $645.19MP/E –Yield –

Bicara Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for Bicara Therapeutics

Bicara Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Bicara Therapeutics figures

See a number that looks wrong?